Search
Miramistin ion
go.drugbank.com/drugs/DB19386InvestigationalMiramistin ion is under investigation in clinical trial NCT05561816 (Efficacy and Safety of Dioxidin Versus Miramistin in Superficial Pyoderma).
Synonyms: Benzenemethanaminium, n,n-dimethyl-n-(3-((1-oxotetradecyl)amino)propyl)-Ipratropium
go.drugbank.com/drugs/DB00332ApprovedInvestigational[A176939] It is commonly administered through inhalation which allows producing a local effect without presenting a significant systemic absorption. … Ipratropium is a quaternary ammonium derivative of [atropine][A176957] that acts as an anticholinergic agent.
Mixtures: NOTECORT 20 MCG / 50 MCG AEROSOL İNHALASYONU, ÇÖZELTİ, 3 ADET, NASOVİNE DUO 0,5 MG + 0,6 MG/ML BURUN SPREYİ, ÇÖZELTİ, 1 ADETProducts: IPRACORT 20 MCG AEROSOL İNHALER, 3 ADET, Dom-ipratropium 250 Mcg/ml (2 Ml)AKV-9
go.drugbank.com/drugs/DB18061ExperimentalSynonyms: 5-((S)-1-(3,5-bis(trifluoromethyl)phenoxy)ethyl)-3-hydroxycyclohex-2-en-1-one, 1,3-Cyclohexanedione, 5-[(1S)-1-[3,5-bis(trifluoromethyl)phenoxy]ethyl]-Dupilumab
go.drugbank.com/drugs/DB12159ApprovedInvestigationalDupilumab is a fully human monoclonal antibody of the immunoglobulin G4 subclass that binds to the interleukin-4 (IL-4) receptor, inhibiting the receptor signaling pathways. … [L7186,L7192,L41439] Dupilumab is currently under investigations for potential therapeutic use in diseases driven by allergic reactions or type 2 inflammation, such as pediatric atopic dermatitis, and
Categories: Interleukin-4 Receptor alpha Antagonist, Interleukin 4 Receptor alpha AntagonistsProducts: DUPİXENT 200 mg/1,14 ml ENJEKSİYONLUK ÇÖZELTİ İÇEREN KULLANIMA HAZIR ENJEKTÖR, 2 ADET, DUPİXENT 200 mg/1,14 ml ENJEKSİYONLUK ÇÖZELTİ İÇEREN KULLANIMA HAZIR ENJEKTÖR, 3 ADETCDD-0102
go.drugbank.com/drugs/DB16945ExperimentalSynonyms: 5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine, Pyrimidine, 5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydro-Categories: Heterocyclic Compounds, 1-Ring, Receptor, Muscarinic M1, agonistsTetradecylthioacetic acid
go.drugbank.com/drugs/DB18802InvestigationalSynonyms: Acetic acid, 2-(tetradecylthio)-, 1-(carboxymethylthio)tetradecaneCategories: Compounds used in a research, industrial, or household settingKL1333
go.drugbank.com/drugs/DB17622InvestigationalSynonyms: 2-(1-methylethyl)-3h-naphth(1,2-d)imidazole-4,5-dione, 3h-naphth(1,2-d)imidazole-4,5-dione, 2-(1-methylethyl)-U-0126
go.drugbank.com/drugs/DB17060ExperimentalU-0126 is a direct inhibitor of the mitogen-activated protein-kinase kinase family members, MEK-1 and MEK-2.[A253162]
Salts: U-0126-EtOHSynonyms: Butanedinitrile, bis(amino((2-aminophenyl)thio)methylene)-, (2z,3z)-, 1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadieneDOTA-Arg-Pro-Lys-Pro-Gln-Gln-Phe-2Thi-Gly-Leu-Met(O2)-NH2 Actinium AC-225
go.drugbank.com/drugs/DB18208ExperimentalSynonyms: -2-amino-4-(methylsulfonyl)-, (2S)-, [225Ac]Butanamide, N2-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-L-arginyl-L-prolyl-L-lysyl-L-prolyl-L-glutaminyl-L-glutaminyl-L-phenylalanyl-3-(2-thienyl)-L-alanylglycyl-L-leucylMethylprednisolone
go.drugbank.com/drugs/DB00959ApprovedInvestigationalVet approvedMethylprednisolone is a [prednisolone] derivative glucocorticoid with higher potency than [prednisone].[A188811] It was first described in the literature in the late 1950s. … [A188811,A188814] Methylprednisolone was granted FDA approval on 24 October 1957.
Mixtures: Physicians EZ Use M-pred, Physicians EZ Use M-predCategories: P-glycoprotein inducers, P-glycoprotein substrates